Benzaldehyde

Benzaldehyde

SCHEMBL531470

CC(O)CO.CCOC(C)OCC.O=Cc1ccccc1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Benzaldehyde. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CYP2A6 P11509 1/20 0.44
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 2/20 0.38
NR1I2 O75469 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A3 P47895 1/20 0.35
PPARA Q07869 4/20 0.34
PPARD Q03181 3/20 0.34
PPARG P37231 2/20 0.34
TYR P14679 1/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
RELA Q04206 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzaldehyde SCHEMBL872657 0.92 ALDH1A1 (0.42) ALDH1A1CYP2A6KMT2AMEN1LMNA
Benzaldehyde SCHEMBL4954589 0.90 ALDH1A1 (0.47) ALDH1A1CYP2A6KMT2AMEN1LMNA
Benzaldehyde SCHEMBL367504 0.90 ALDH1A1 (0.54) ALDH1A1CYP2A6KMT2AMEN1LMNA
Sorbitol SCHEMBL1276725 0.90 ALDH1A1 (0.40) ALDH1A1CYP2A6KMT2AMEN1LMNA
Benzaldehyde SCHEMBL17698491 0.87 ALDH1A1 (0.38) ALDH1A1CYP2A6KMT2AMEN1LMNA
Benzaldehyde SCHEMBL11346796 0.87 ALDH1A1 (0.50) ALDH1A1CYP2A6KMT2AMEN1LMNA
Benzaldehyde SCHEMBL2536104 0.87 ALDH1A1 (0.58) ALDH1A1CYP2A6KMT2ALMNAL3MBTL1
Benzaldehyde SCHEMBL10821733 0.86 ALDH1A1 (0.42) ALDH1A1CYP2A6KMT2AMEN1LMNA
Cinnamic Aldehyde SCHEMBL8740777 0.85 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1LMNAL3MBTL1
Benzaldehyde SCHEMBL19924275 0.84 ALDH1A1 (0.47) ALDH1A1CYP2A6KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12496370-B2 Freshening compositions comprising controlled release modulators Arylessence, Inc. (US) 2025-12-16 US claimed
CN-119867364-A Electronic atomized liquid with fruit fragrance 思摩尔国际控股有限公司 2025-04-25 CN claimed
CN-119614292-A Dried apricot water-soluble essence and preparation method and application thereof 山东将军烟草新材料科技有限公司 2025-03-14 CN claimed
CN-119534683-A Identification method of volatile biomarker of kiwi fruit soft rot and identification method of soft rot 陕西师范大学 2025-02-28 CN claimed
CN-119111761-A Guava essence and preparation method thereof 东莞奇易香料有限公司 2024-12-13 CN claimed
CN-118902055-A Apricot essence and preparation method thereof 江西锡曼食品科技有限责任公司 2024-11-08 CN claimed
CN-118452168-A Hexagon essence and preparation method and application thereof 上海熙美源实业有限公司 2024-08-09 CN claimed
CN-118402594-A Preparation method of cherry essence for carbonated beverage 四川味欣生物科技有限公司 2024-07-30 CN claimed
US-11806448-B2 Freshening compositions comprising controlled release modulators Arylessence, Inc. (US) 2023-11-07 US claimed
CN-112924609-B Method for analyzing volatile aroma components contained in bead blasting filter stick 福建中烟工业有限责任公司 2023-02-03 CN claimed
EP-1183053-B1 COMPOSITION AND METHOD FOR DISINFECTING THE AIR SCHUER JOERG-PETER PROF (DE) 2005-04-20 EP claimed
JP-2005509662-A 2005-04-14 JP claimed
CN-1589136-A Pharmaceutical and cosmetic compositions containing aromatic aldehydes bearing oxygen-containing groups CUTANIX CORP (US) 2005-03-02 CN claimed
US-20050014827-A1 Synergistic medicament containing flavoring agents and having an antagonistic regenerative and/or protagonist decontamination effect SCHUR JORG P (DE) 2005-01-20 US claimed
WO-2004091307-A2 FEED ADDITIVES AGAINST DISEASSE INFECTION IN TERRESTRIAL AND AQUATIC ANIMALS ADVANCED BIONUTRITON CORPORATION (US) 2004-10-28 WO claimed
EP-1443915-A1 PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES Cutanix Corporation (US) 2004-08-11 EP claimed
US-20040076614-A1 Symbiotic regenerative agent SCHUR JORG P (DE) 2004-04-22 US claimed
US-20030157154-A1 Compositions containing hydroxy aromatic aldehydes and their use in treatments CUTANIX CORPORATION 2003-08-21 US claimed
WO-2003043621-A1 PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES CUTANIX CORPORATION (US) 2003-05-30 WO claimed
EP-0762837-B1 PROCESS FOR IMPROVING THE SHELF LIFE OF AND/OR STABILISING PRODUCTS WHICH CAN SPOIL UNDER THE ACTION OF MICROBES SCHUER JOERG PETER PROF (DE) 2002-02-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030157154-A1 Compositions containing hydroxy aromatic aldehydes and their use in treatments TYR, HRH1, HRH2 ALDH1A1 7/4885CYP2A6 353/4885KMT2A 2715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.